IMpower010：Final DFS results from adjuvant atezolizumab in Japanese patients with resected NSCLC

Yasutaka Watanabe

Presentation information

ワークショップ

ワークショップ10 周術期治療の到達点と課題

Fri. Nov 1, 2024 10:10 AM - 11:40 AM 第3会場 (パシフィコ横浜ノース 3階 G301+G302)

座長：田中文啓(産業医科大学第2外科学), 野上尚之(愛媛大学大学院医学系研究科地域胸部疾患治療学講座)

[WS10-3] IMpower010：Final DFS results from adjuvant atezolizumab in Japanese patients with resected NSCLC

^○Yasutaka Watanabe¹, Morihito Okada², Hirotsugu Kenmotsu³, Shunichi Sugawara⁴, Haruhiro Saito⁵, Toyofumi Fengshi Chen-Yoshikawa⁶, Yuichiro Ohe⁷, Wataru Nishio⁸, Shizuka Nakagawa⁹, Morihiko Hayashi⁹ (1.Saitama Cancer Center, 2.Hiroshima University, 3.Shizuoka Cancer Center, 4.Sendai Kousei Hospital, 5.Kanagawa Cancer Center, 6.Nagoya University Graduate School of Medicine, 7.National Cancer Center, 8.Hyogo Cancer Center, 9.Chugai Pharmaceutical Co., Ltd.)

アンコール演題

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.